208 related articles for article (PubMed ID: 17196876)
1. Debate on annual influenza vaccination in healthcare workers for the same subtype under the vaccine shortage.
Song JY; Ha SH; Kee SY; Jeong HW; Cheong HJ; Kim WJ
J Clin Virol; 2007 Feb; 38(2):149-52. PubMed ID: 17196876
[TBL] [Abstract][Full Text] [Related]
2. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
3. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.
Nabeshima S; Kashiwagi K; Murata M; Kanamoto Y; Furusyo N; Hayashi J
J Med Virol; 2007 Mar; 79(3):320-5. PubMed ID: 17245715
[TBL] [Abstract][Full Text] [Related]
4. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G
Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951
[TBL] [Abstract][Full Text] [Related]
5. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?
Skowronski DM; Tweed SA; De Serres G
J Infect Dis; 2008 Feb; 197(4):490-502. PubMed ID: 18275271
[TBL] [Abstract][Full Text] [Related]
6. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
Zuccotti G; Amendola A; Viganò A; Pariani E; Zappa A; Pogliani L; Giacomet V; Savarino A; Podestà A; Rottoli A; Tanzi E; Zanetti A; Radaelli G
Vaccine; 2007 Sep; 25(37-38):6692-8. PubMed ID: 17697730
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older.
Kerzner B; Murray AV; Cheng E; Ifle R; Harvey PR; Tomlinson M; Barben JL; Rarrick K; Stek JE; Chung MO; Schödel FP; Wang WW; Xu J; Chan IS; Silber JL; Schlienger K
J Am Geriatr Soc; 2007 Oct; 55(10):1499-507. PubMed ID: 17908055
[TBL] [Abstract][Full Text] [Related]
8. Immune response after influenza vaccination in children with cancer.
Matsuzaki A; Suminoe A; Koga Y; Kinukawa N; Kusuhara K; Hara T
Pediatr Blood Cancer; 2005 Nov; 45(6):831-7. PubMed ID: 16007602
[TBL] [Abstract][Full Text] [Related]
9. Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002-2003).
Michiels B; Philips H; Coenen S; Denekens J; Van Royen P
Vaccine; 2006 Apr; 24(16):3145-52. PubMed ID: 16490288
[TBL] [Abstract][Full Text] [Related]
10. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
Sugimura T; Ito Y; Tananari Y; Ozaki Y; Maeno Y; Yamaoka T; Kudo Y
Vaccine; 2008 May; 26(22):2700-5. PubMed ID: 18436353
[TBL] [Abstract][Full Text] [Related]
11. Serological response to influenza vaccine after hematopoetic stem cell transplantation.
Yalçin SS; Kondolot M; Albayrak N; Altaş AB; Karacan Y; Kuşkonmaz B; Aksu S; Cetin M; Göker H; Yurdakök K; Uçkan D
Ann Hematol; 2010 Sep; 89(9):913-8. PubMed ID: 20119669
[TBL] [Abstract][Full Text] [Related]
12. Influenza vaccine 2008-2009.
Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032
[TBL] [Abstract][Full Text] [Related]
13. Immune response to influenza vaccination in community-dwelling Chinese elderly persons.
Hui SL; Chu LW; Peiris JS; Chan KH; Chu D; Tsui W
Vaccine; 2006 Jun; 24(25):5371-80. PubMed ID: 16713661
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses after dose-sparing intradermal influenza vaccination.
Auewarakul P; Kositanont U; Sornsathapornkul P; Tothong P; Kanyok R; Thongcharoen P
Vaccine; 2007 Jan; 25(4):659-63. PubMed ID: 17011678
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S
Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930
[TBL] [Abstract][Full Text] [Related]
17. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial.
Cools HJ; Gussekloo J; Remmerswaal JE; Remarque EJ; Kroes AC
J Med Virol; 2009 May; 81(5):908-14. PubMed ID: 19319953
[TBL] [Abstract][Full Text] [Related]
18. Cross-protection against homologous drift variants of influenza A and B after vaccination with split vaccine.
Heckler R; Baillot A; Engelmann H; Neumeier E; Windorfer A
Intervirology; 2007; 50(1):58-62. PubMed ID: 17164559
[TBL] [Abstract][Full Text] [Related]
19. Comparison of immune response to the influenza vaccine in obese and nonobese healthcare workers.
Sweet MA; McCullers JA; Lasala PR; Briggs FE; Smithmyer A; Khakoo RA
Infect Control Hosp Epidemiol; 2015 Mar; 36(3):249-53. PubMed ID: 25695164
[TBL] [Abstract][Full Text] [Related]
20. Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence.
Song JY; Cheong HJ; Hwang IS; Choi WS; Jo YM; Park DW; Cho GJ; Hwang TG; Kim WJ
Vaccine; 2010 May; 28(23):3929-35. PubMed ID: 20394719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]